Short Interest in XOMA Co. (NASDAQ:XOMAP) Decreases By 50.0%

XOMA Co. (NASDAQ:XOMAP) was the target of a significant decline in short interest in the month of October. As of October 15th, there was short interest totalling 2,900 shares, a decline of 50.0% from the September 30th total of 5,800 shares. Based on an average daily volume of 2,000 shares, the short-interest ratio is currently 1.5 days.

XOMA Price Performance

XOMAP opened at $26.49 on Monday. The firm has a 50 day moving average of $25.77 and a two-hundred day moving average of $25.46. XOMA has a 12-month low of $21.40 and a 12-month high of $26.51.

About XOMA

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets.